CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Millions	Total	Cumulative Effect, Period of Adoption, Adjustment	[1]	Common Stock and Additional Paid-In Capital	Common Stock and Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment	[1]	Accumulated Other Comprehensive Income (Loss)	Retained Earnings (Accumulated Deficit)	Retained Earnings (Accumulated Deficit) Cumulative Effect, Period of Adoption, Adjustment	[1]
Beginning balance (in shares) at Apr. 01, 2022				582,000,000
Beginning balance at Apr. 01, 2022	$ (93)	$ (1)		$ 1,851	$ (7)		$ (4)	$ (1,940)	$ 6
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	200							200
Other comprehensive income (loss), net of taxes	(40)						(40)
Common stock issued under employee stock incentive plans (in shares)				2,000,000
Shares withheld for taxes related to vesting of restricted stock units (in shares)				(1,000,000)
Shares withheld for taxes related to vesting of stock units	$ (16)			$ (16)
Repurchases of common stock (in shares)	(12,000,000)			(12,000,000)
Repurchases of common stock	$ (300)			$ (300)
Cash dividends declared and dividend equivalents accrued	(73)			(73)
Stock-based compensation	24			$ 24
Ending balance (in shares) at Jul. 01, 2022				571,000,000
Ending balance at Jul. 01, 2022	$ (299)			$ 1,479			(44)	(1,734)
Beginning balance (in shares) at Mar. 31, 2023	640,000,000			640,000,000
Beginning balance at Mar. 31, 2023	$ 2,200			$ 2,800			(15)	(585)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	189							189
Other comprehensive income (loss), net of taxes	51						51
Common stock issued under employee stock incentive plans (in shares)				3,000,000
Shares withheld for taxes related to vesting of restricted stock units (in shares)				(1,000,000)
Shares withheld for taxes related to vesting of stock units	$ (18)			$ (18)
Repurchases of common stock (in shares)	(3,000,000)			(3,000,000)
Repurchases of common stock	$ (41)			$ (41)
Cash dividends declared and dividend equivalents accrued	(81)			(81)
Stock-based compensation	$ 37			$ 37
Ending balance (in shares) at Jun. 30, 2023	639,000,000			639,000,000
Ending balance at Jun. 30, 2023	$ 2,337			$ 2,697			$ 36	$ (396)

[1] Effective on April 2, 2022, the Company adopted ASU 2020-06 (Debt with Conversion and Other Options, ASC 470-20) using a modified retrospective method.